D3 Decision definition
D3 Decision means the decision by Bayer whether or not to continue the development of a Product following the review of the data and information as further described in Exhibit A.
D3 Decision means the decision of the committee within Bayer, which is responsible to take this decision according to the internal guidelines of Bayer set forth on Exhibit 1.31, to initiate preclinical development with regard to the Antibody or a Licensed Product.